|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao P, Wang JG, Gao P, Li X and Brewer R:
Sudden unexpected death from natural diseases: Fifteen years'
experience with 484 cases in Seychelles. J Forensic Leg Med.
37:33–38. 2016. View Article : Google Scholar
|
|
3
|
Meguro M, Mizuguchi T, Kawamoto M and
Hirata K: The molecular pathogenesis and clinical implications of
hepatocellular carcinoma. Int J Hepatol. 2011:8186722011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu Z, Liang L, Wang H, Li T and Zhao M:
HCRP1, a novel gene that is downregulated in hepatocellular
carcinoma, encodes a growth-inhibitory protein. Biochem Biophys Res
Commun. 311:1057–1066. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wittinger M, Vanhara P, El-Gazzar A,
Savarese-Brenner B, Pils D, Anees M, Grunt TW, Sibilia M, Holcmann
M, Horvat R, et al: hVps37A Status affects prognosis and cetuximab
sensitivity in ovarian cancer. Clin Cancer Res. 17:7816–7827. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perisanidis C, Savarese-Brenner B, Würger
T, Wrba F, Huynh A, Schopper C, Kornek G, Selzer E, Ewers R, Psyrri
A, et al: HCRP1 expression status is a significant prognostic
marker in oral and oropharyngeal cancer. Oral Dis. 19:206–211.
2013. View Article : Google Scholar
|
|
8
|
Xu J, Yang W, Wang Q, Zhang Q, Li X, Lin
X, Liu X and Qin Y: Decreased HCRP1 expression is associated with
poor prognosis in breast cancer patients. Int J Clin Exp Pathol.
7:7915–7922. 2014.
|
|
9
|
Yang W, Wang JG, Wang Q, Qin Y, Lin X,
Zhou D, Ren K, Hou C, Xu J and Liu X: Decreased HCRP1 promotes
breast cancer metastasis by enhancing EGFR phosphorylation. Biochem
Biophys Res Commun. 477:222–228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du Y, Wang P, Sun H, Yang J, Lang X, Wang
Z, Zang S, Chen L, Ma J and Sun D: HCRP1 is downregulated in
non-small cell lung cancer and regulates proliferation, invasion,
and drug resistance. Tumour. 37:15893–15901. 2016. View Article : Google Scholar
|
|
11
|
Bache KG, Slagsvold T, Cabezas A, Rosendal
KR, Raiborg C and Stenmark H: The growth-regulatory protein
HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates
receptor down-regulation. Mol Biol Cell. 15:4337–4346. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Voutsadakis IA: Epithelial-mesenchymal
transition (EMT) and regulation of EMT factors by steroid nuclear
receptors in breast cancer: A review and in silico investigation. J
Clin Med. 5:E112016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wendt MK, Tian M and Schiemann WP:
Deconstructing the mechanisms and consequences of TGF-β-induced EMT
during cancer progression. Cell Tissue Res. 347:85–101. 2012.
View Article : Google Scholar
|
|
14
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Zijl F, Mall S, Machat G, Pirker C,
Zeillinger R, Weinhaeusel A, Bilban M, Berger W and Mikulits W: A
human model of epithelial to mesenchymal transition to monitor drug
efficacy in hepatocellular carcinoma progression. Mol Cancer Ther.
10:850–860. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Zijl F, Zulehner G, Petz M, Schneller
D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H and Mikulits
W: Epithelial-mesenchymal transition in hepatocellular carcinoma.
Future Oncol. 5:1169–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duivenvoorden WC, Hirte HW and Singh G:
Transforming growth factor beta1 acts as an inducer of matrix
metalloproteinase expression and activity in human
bone-metastasizing cancer cells. Clin Exp Metastasis. 17:27–34.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai MW, Huang SF, Lin SM, Chen TC, Lin CY,
Yeh CN, Yeh TS, Chen MF and Yeh CT: Expression of the HCRP1 mRNA in
HCC as an independent predictor of disease-free survival after
surgical resection. Hepatol Res. 39:164–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giannelli G, Villa E and Lahn M:
Transforming growth factor-β as a therapeutic target in
hepatocellular carcinoma. Cancer Res. 74:1890–1894. 2014.
View Article : Google Scholar : PubMed/NCBI
|
